Results 181 to 190 of about 7,486,166 (326)
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Regarding "Internet Resources for Highway Engineering"
Cindy Kerckhoffs
doaj +1 more source
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer. [PDF]
Sampathkumar Y +25 more
europepmc +1 more source
The New York Vegetable Industry Situation and Trends Extension Programming
R. Brian How, How, R. Brian
openalex +2 more sources
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley +1 more source
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley +5 more
wiley +1 more source
Yuh-Shan Ho
doaj +1 more source
Trend analysis of dam inflow data using the trend accuracy index and the potential-evapotranspiration correction factor. [PDF]
Wang WJ, Kim HS.
europepmc +1 more source

